Funder: National Institutes of Health
Due Dates: June 9, 2025 (Full application) | May 10, 2025 (Letter of Intent, optional)
Funding Amounts: Up to $1,500,000 direct costs/year for up to 5 years; budgets should match project scope and complexity.
Summary: Supports interdisciplinary teams to investigate mechanisms of pain relief by FDA-approved or -cleared medical devices, aiming to optimize non-opioid pain therapies.
Key Information: Requires at least 3 PDs/PIs from domestic institutions; clinical trial optional but only mechanistic or BESH trials are in scope.